RE:RE:RE:RE:RE:RE:RE:RE:RE:The Comapny Performed, Management disappointed. Health123 wrote:
Prakash was asking about the number of new formulas on "a proportion basis" This was not out of line as another poster on this board has said.
[...]
Borkowski's response "we are not going to give out this kind of detail" is not acceptable for a public company.
(1) Prakash was out of line, and Bork responded correctly. There should be NO questions about unlaunched products unless the market already knows about them. If you can't see the importance of this, consider the fallout if Bork had responded, "There are no new formulas coming in the next year." Then what do you think would have happened to the share price yesterday? 70% down? More? Remember, the competitors were on the CXR call too, and they'll be playing it again and again to see if CXR let anything slip -- anything that suggests an attackable vulnerability in market share.
.